急性心脏毒性是抗菌药物治疗过程中日益引起重视的潜在不良反应，其中大环内酯类抗生素能够干扰延迟整流钾电流从而延迟心肌复极化，引起QT间期的延长，潜在的能够增加尖端扭转室速风险，被认为具有心源性猝死风险。为此，丹麦学者Henrik Svanström等通过大型队列研究评估心脏死亡风险与克拉霉素和罗红霉素使用之间的关系

报道，美国德克萨斯州的AkeelM.Merchant医生报道了一例全髋关节翻修术后坐骨应力骨折，发表在2014年9月的The&nbsp...，但是髋臼下方的骨折并无明显变化（见图2A和2B）。一年以后的X线片显示髋臼假体下方的骨折线仍有2cm的间隙，而耻骨联合部位坐骨下支的骨折线则骨性愈合，患者右髋

        分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析（GWAS）为全面系统研究复杂疾病的遗传因素掀开了新的一页，为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因，我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目，吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员，特别是广大研究生了解GWAS的研究原理和方法，学会设计GWAS的研究和分析实验结果，同时在癌症领域分享海内外研究专家们的成功经验，并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加，请有意者及时将回执返回联系邮箱。免注册费（食宿餐饮费用自理）。名额有限，报名从速！时间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆 上海市邯郸路220号，200433
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹 高歌 联系电话： 021-55664495
回执邮箱： GWAS2009@gmail.com
 BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时　　间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹，高歌 (Shanghai, China)；Tamara Adams (U.S.)
联系电话： 21-55664495 (Shanghai, China)；336-713-7532 (U.S.)
回执邮箱： GWAS2009@gmail.com (Shanghai, China)；tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer
 

曹彬 主任医师，教授中日医院呼吸中心常务副主任经王辰院士推荐，经《新英格兰医学杂志》（NEJM）杂志主编 Jeffrey M. Dr.... 教授今年 70 岁，他不仅是 NEJM 的主编，还是哈佛医学院 Parker B. Francis 杰出教授，Brigham and Women’s

（80ml/m）至200ml时，逼尿肌压力上升到15cmH2O， 灌水至400ml时，逼尿肌压力缓慢上升到70cmH2O，；病人膀胱感觉很差，灌水至400ml时...长度也是一个很重要的参数指标。2. B超提示前列腺的大小为多少？有无膀胱及尿道结石？3. 从这张压力流率图来看，也有不近如人意的地方，如EMG参数没有；当灌注

临床常用的雾化吸入药物主要有吸入性糖皮质激素（ICS）、短效 β2 受体激动剂（SABA）短效胆碱 M 受体拮抗剂（SAMA）和黏液溶解剂等几大类。＞＞点击...稀释。用法用量：4. 硫酸特布他林雾化吸入用溶液 未明确说明。✦将小瓶中溶液挤入雾化器贮液器中。✦本品雾化液不可与碱性溶液即 pH 大于 7 的溶液

案例再现请看来自于论坛站友的病例分享：基本资料：患者，男性，52 岁。确诊鼻咽癌 2 月余，要求放化疗入院。入院诊断：1. 鼻咽癌 cT3N0M0 Ⅲ期 2....参考文献1. 彭月，向志碧. 尼妥珠单抗在鼻咽癌治疗中的研究进展. 肿瘤预防与治疗，2020，33（7）.2. 韩艳茹，于洪江. 尼妥珠单抗

看到战友@jo***m在丁香园论坛求助关于咯血抢救的问题：小弟目前在呼吸科轮转，咯血病人不少，网上说大量咯血几百毫升的病人抢救时候要头...咯血的 7 大病因2. 大咯血的急救流程3. 大咯血抢救 ABC 三部曲首发 |呼吸时间排版 |Rabbit责编|飞腾题图

，克利夫兰诊所的Eileen M. Hsich博士等进行了一项研究，比较OHT候选患者生存率的性别差异。研究发现，男性和女性在OHT的候选过程中的生存率确实...评价生存率的性别差异。数据显示，等待OHT的患者共有28,852名（24%女性），其中6,163名患者UNOS状态为1A级（25%女性），9,168名为1B级

丁香园站友 @小笼包 0825 最近发布另一个非常有价值的病例。病例介绍：诊断：急性髓系白血病（M2）；化疗后骨髓抑制；败血症（脓毒症）。血培养：产酸克雷伯...；②患者疾病不稳定；③预期患者的粒缺状态 (ANC<100/mm3)，≥ 7 天；④肌酐>2 mg/dL，肝功能> 正常值的 3 倍；⑤肿瘤

抗体结合到足细胞固有的抗原时，就会形成上皮侧的原位免疫复合物沉积。抗 M 型磷脂酶 2 受体（PLA2R）是原发性 MN 的主要靶抗原，Ⅰ型血小板域蛋白 7A（THSD7A）近期被确认为第二靶抗原。随着近年来诊断方法学的飞速发展，对 MN 的诊断、鉴别诊断、治疗、预后分析研究越来越多，来自波士顿大学的 David J.

一文了解医疗界那些事，实时追踪时事热点【医界头条】1.世卫组织：医护人员确诊病例占全球的 10%2.3M 与麻省理工研究人员合作开发新冠...卫健委、公安厅联合发布《关于健全完善道路交通事故警医联动救援救治长效机制的通知》7 月 17 日，国家卫生健康委办公厅于 7 月 17 日，联合印发了《公安部

视野测试，结果显示不同程度的周边缺损或环状暗点，光学相干断层扫描（OCT）显示患者均有 CME，黄斑中心凹厚度为 206～651μm，中央视网膜外核层变薄，这指示

共场所受到行政处罚。（来源：药明康德、药时代、新华网、新京报、中国经济网）【行业动态】国务院办公厅：将符合条件的互联网医疗服务纳入医保报销范围7...的通知》7 月 20 日，四川省医疗保障局印发《关于公布四川省 2020 年第一批新增医疗服务项目试行价格的通知》，对 16 个新增医疗服务项目制定了试行价格

1985 年德国医师 Mühe 在直视镜下进行了首例腹腔镜胆囊切除术（LC）。在1992 年，美国国立卫生研究院（NIH）达成专家共识，认为除了...效？两种方法都被证明是有效的。（B 级）对于伴随的胆总管结石和胆囊结石，多项 RCT 和荟萃分析显示，一期（腹腔镜胆总管探查加腹腔镜胆囊切除术或术中 ERCP）和二期

；3. OPEN-TLIF 才是王道！不难看出，虽然 MIS-TLIF 技术已经成熟的被应用于脊柱疾病的治疗中，但是关于其相对于开放手术是否具有优势的争论从未停息

武汉新型冠状病毒已经在全国迅速蔓延，截止 2020 年 1 月 30 日，已累计确诊超过 7 千人，死亡 170 例，疑似病例超万例。新型冠状病毒疫情已成为继 SARS、MERS 之后全球面临的最大规模公共卫生事件。当前，新型冠状病毒感染的肺炎疫情正在蔓延，快速准确检测病毒并确诊感染患者，是疫情防治工作的重中之重

癌（LCIS-1）● 导管原位癌（DCIS-1~2，A）浸润性乳腺癌：● 临床分期为I、IIA、IIB或IIIA（仅T3，N1，M0）期的检查（BINV-1）● 临床分期为I、IIA、IIB或IIIA（仅T3，N1，M0）期的局部治疗（BINV-2~3）● 全身辅助治疗（BINV-4~9